Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Digestive Diseases and Sciences
|
May 1, 1996
Clinical value of duodenojejunal manometry. Its usefulness in diagnosis and management of patients with gastrointestinal symptoms
E Soffer, S Thongsawat
Digestive Diseases and Sciences
|
May 1, 1997
Small bowel manometry: short or long recording sessions?
E E Soffer, S Thongsawat
The American Journal of Gastroenterology
|
August 26, 1998
Prolonged ambulatory duodeno-jejunal manometry in humans: normal values and gender effect
E E Soffer, S Thongsawat, S Ellerbroek
Digestive Diseases and Sciences
|
February 10, 1999
Effect of acute hyperglycemia on jejunal compliance and peristaltic reflex in healthy humans
E E Soffer, S Thongsawat, B J Hoogwerf, et al.
Journal of Viral Hepatitis
|
October 20, 2010
Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy
K Kumthip, C Pantip, P Chusri, et al.
Gut
|
April 15, 2003
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
J Kellow, O Y Lee, F Y Chang, et al.
Journal of Viral Hepatitis
|
March 16, 2013
Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
Y Wang, S Thongsawat, E J Gane, et al.
Journal of Viral Hepatitis
|
August 7, 2012
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3
S Pianko, S Zeuzem, W-L Chuang, et al.
Alimentary Pharmacology & Therapeutics
|
August 5, 2015
Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)
S Zeuzem, R Flisiak, J M Vierling, et al.
Journal of Viral Hepatitis
|
March 16, 2013
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
G R Foster, S Zeuzem, S Pianko, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Digestive Diseases and Sciences
|
May 1, 1996
Clinical value of duodenojejunal manometry. Its usefulness in diagnosis and management of patients with gastrointestinal symptoms
E Soffer, S Thongsawat
Digestive Diseases and Sciences
|
May 1, 1997
Small bowel manometry: short or long recording sessions?
E E Soffer, S Thongsawat
The American Journal of Gastroenterology
|
August 26, 1998
Prolonged ambulatory duodeno-jejunal manometry in humans: normal values and gender effect
E E Soffer, S Thongsawat, S Ellerbroek
Digestive Diseases and Sciences
|
February 10, 1999
Effect of acute hyperglycemia on jejunal compliance and peristaltic reflex in healthy humans
E E Soffer, S Thongsawat, B J Hoogwerf, et al.
Journal of Viral Hepatitis
|
October 20, 2010
Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy
K Kumthip, C Pantip, P Chusri, et al.
Gut
|
April 15, 2003
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
J Kellow, O Y Lee, F Y Chang, et al.
Journal of Viral Hepatitis
|
March 16, 2013
Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
Y Wang, S Thongsawat, E J Gane, et al.
Journal of Viral Hepatitis
|
August 7, 2012
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3
S Pianko, S Zeuzem, W-L Chuang, et al.
Alimentary Pharmacology & Therapeutics
|
August 5, 2015
Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)
S Zeuzem, R Flisiak, J M Vierling, et al.
Journal of Viral Hepatitis
|
March 16, 2013
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
G R Foster, S Zeuzem, S Pianko, et al.
Page
of 1